Skip to content

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control

Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control. The ProMOC Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06647472
Acronym
ProMOC
Enrollment
20
Registered
2024-10-17
Start date
2024-11-15
Completion date
2026-12-01
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Myopia, Orthokeratology

Brief summary

The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future. The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control. Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.

Interventions

None listed

Sponsors

Vejle Hospital
Lead SponsorOTHER
University of Aarhus
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Years to 14 Years

Inclusion criteria

* Children treated with orthokeratology lenses. * Children on or above the 95th percentile of myopia growth curves for European children at the time of treatment initiation. * Treatment and follow-up duration ≥ 6 months.

Exclusion criteria

* Current use of eye drops. * Objective signs of dry eyes on slit-lamp examination. * Active eye infection.

Design outcomes

Primary

MeasureTime frame
Difference in protein levels measured by mass spectrometry label-free quantification (LFQ) between children using orthokeratology lenses with different levels of myopia control effectivenessAt baseline

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026